Intensity-modulated radiation therapy in gynecologic cancers: Growing support, growing acceptance

Cancer Journal

Volumn 14, Issue 3, 2008, Pages 198-199

  Mell, Loren K ^a   Mundt, Arno J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ENDOMETRIUM CANCER; FOLLOW UP; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NOTE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; FEMALE; FEMALE GENITAL TRACT TUMOR; HEALTH PERSONNEL ATTITUDE; PELVIS; RADIATION EXPOSURE;

ATTITUDE OF HEALTH PERSONNEL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PELVIS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 52649110646     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e318178dda1     Document Type: Note

References (12)

1. Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52:1330-1337.
2. Mell LK, Roeske JC, Mundt AJ. A survey of intensity-modulated radiation therapy use in the United States. Cancer. 2003;98:204-211.
3. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104:1296-1303.
4. Chen MF, Tseng CJ, Tseng CC, et al. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J. 2008;14: 200-206.
5. Beriwal S, Jain SK, Heron DE, et al. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. Gynecol Oncol. 2006;102:195-199.
6. Beriwal S, Gan GN, Heron DE, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2007;68:166- 171.
7. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51:261-266.
8. Mutic S, Malyapa RS, Grigsby PW, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes - a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys. 2003;55:28-35.
9. Beriwal S, Heron DE, Kim H, et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys. 2006;64:1395- 1400.
10. Mell LK, Kochanski JD, Roeske JC, et al. Dosimetric predictors of acute hematologic toxicity in cervical caner patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:1356-1365.
11. Guerrero M, Li XA, Ma L, et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys. 2005;62:933-939.
12. van de Bunt L, van der Heided UA, Ketelaars M, et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression. Int J Radiat Oncol Biol Phys. 2006;64:189-196.